Stock APLS APELLIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Apellis Pharmaceuticals, Inc.

Equities

APLS

US03753U1060

Market Closed - Nasdaq
Other stock markets
 01:30:00 11/05/2024 am IST 		5-day change 1st Jan Change
41.99 USD -1.25% Intraday chart for Apellis Pharmaceuticals, Inc. -11.53% -29.85%
09/05 Apellis Pharmaceuticals Insider Sold Shares Worth $3,341,848, According to a Recent SEC Filing MT
08/05 UBS Adjusts Price Target on Apellis Pharmaceuticals to $85 From $89, Maintains Buy Rating MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
APELLIS PHARMACEUTICALS, INC.
Biopharmaceuticals
-1.25%-11.53%-29.85%-52.58%+120.07% 5.1B
Bearish
Bearish
Neutral
  1. Stock Market
  2. Equities
  3. APLS Stock
  4. Charts Apellis Pharmaceuticals, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW